Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
What factors do you consider when choosing between baloxavir and oseltamivir for treating patients with influenza?
Related Questions
What are your top takeaways from IDWeek 2025?
What are your vaccine recommendations while patients are on biologics?
Do you recommend immunomodulating treatments such as steroids or IVIG for West Nile Virus neuroinvasive disease?
Do routinely recommend antifungal prophylaxis for non-transplant patients who have been diagnosed and completed treatment for possible/probable pulmonary aspergillosis and who will need varying degrees of ongoing immunosuppression?
Are there circumstances where you would treat with antibiotics if a catheter tip culture is positive for a pathogenic organism, blood cultures are negative, and the catheter was removed from an ICU patient for suspected infection?
What is your approach to relapsing babesiosis in immunosuppressed patients?
Do you routinely recommend an immunodeficiency work up in patients with ARDS due to influenza infection who develop invasive pulmonary aspergillosis?
Do you routinely recommend treatment for patients with chronic osteomyelitis of long bones based on radiographic findings alone in the absence of superficial infection or recommend bone biopsy to evaluate for therapy?
Which dosing strategy do you typically use for dalbavancin for staph aureus vertebral osteomyelitis?
Are there specific organisms other than s. aureus in which you offer indefinite antibiotic suppression in medically treated prosthetic valve endocarditis?
